Results 31 to 40 of about 8,310 (206)

Osteonecrosis of the jaws in patients treated with bisphosphonates [PDF]

, 2012
The literature describes an increasing presence of bisphosphonate-induced osteonecrosis of the jaws (ONJ), characterized by the exposure for over 8 weeks of necrotic bone in the maxillofacial region, after bisphosphonate therapy, in the absence of ...
Ata-Ali Mahmud, Fadi, Ata-Ali Mahmud, Francisco Javier, Bagán Sebastián, José Vicente, Flichy Fernández, Antonio   +3 more
core   +1 more source

RANK-Ligand inhibitor associated osteonecrosis of the jaw

GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW, 2013
Osteonecrosis of the jaw may be caused by many different triggers. One of them is described to be the drug or medication related osteonecrosis of the jaw. Since many years bisphosphonates induced the dreaded diagnosis.
Rashad, Ashkan, Smeets, Ralf, Heiland, Max   +2 more
doaj   +1 more source

Mechanisms Underlying Medication-Related Osteonecrosis of the Jaw. [PDF]

Oral Dis
ABSTRACT Objective Medication‐related osteonecrosis of the jaw (MRONJ) is a rare but debilitating disease characterized by a progressive necrosis of jaw bones in patients who have received anti‐resorptive or anti‐angiogenic therapies.
Lee K, Kim K, Kim JY, Kim JW, Kang YH, Kim YH, Kim SJ.   +6 more
europepmc   +3 more sources

Sinusitis and oroantral fistula in patients with bisphosphonate-associated necrosis of the maxilla [PDF]

, 2016
BACKGROUND: The management of bisphosphonate related necrosis of the jaw has become clinical routine. While approximately two thirds of the lesions are in the mandible, one third is located in the maxilla.
Andres Stricker, Gido Bittermann, Gustavo Vargas Soto, Kiwako Izumi, Philipp Poxleitner, Pit Jacob Voss, Rainer Schmelzeisen   +6 more
core   +1 more source

An unusual case of bone regeneration of a necrotic mandible with pathologic fracture in an elderly hemodialysis patient with medication-related osteonecrosis of the jaw: a case report and review of the literature

Journal of Medical Case Reports, 2021
Background Bisphosphonates are frequently used for osteoporosis. Medication-related osteonecrosis of the jaw, a complication of bone-modifying agents, including bisphosphonates or angiogenic inhibitors, can be challenging to treat in elderly patients ...
Kunio Yoshizawa, Akinori Moroi, Ran Iguchi, Akihiro Takayama, Junko Goto, Yutaka Takayama, Koichiro Ueki   +6 more
doaj   +1 more source

Comments on "diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus" [PDF]

, 2015
Letter to ...
Assaf, Bedogni, Bedogni, Carlson, Colella, Fedele, Fedele, Fliefel, Graziani, Hoff, Holmdahl, Humphrey, Hutchinson, Jacobsen, Junquera, Khan, Kyrgidis, Liberati, Mawardi, Mucke, Nicolatou-Galitis, Noordzij, Otto, Patel, Pautke, Peters, Ruggiero, Ruggiero, Rupel, Schiodt, Schubert, Scully, Sharif, Sonnier, Stockmann, Then, Vescovi, Walter, Yarom, Yuan   +39 more
core   +1 more source

Dental implants in patients treated with oral bisphosphonates. A bibliographic review [PDF]

, 2009
Bisphosphonates inhibit bone resorption and are used to treat a range of pathologies, including Paget disease, osteoporosis, multiple myeloma and metastases associated with breast or prostate cancer.
Calvo Guirado, José Luis, Monpeán Gambín, Mª del Carmen, Montoya Carralero, José Mª, Morata Murcia, Isabel Mª, Parra Mino, Pablo, Ramírez Fernández, Piedad   +5 more
core   +1 more source

Medication-related Osteonecrosis of the Jaw [PDF]

Radiology, 2021
null Sajeev R. Ezhapilli Chennan, MBBS, null Maria Andrea Parra Corral, MD, null Ronald T. Smith Jr, MD, null Claudia Jordan-Guedes   +3 more
openaire   +3 more sources

Intraosseous Squamous Cell Carcinoma Associated with Denosumab-Induced Osteonecrosis of the Jaw

Applied Sciences, 2021
Medication-related osteonecrosis of the jaw (MRONJ) has been associated with the use of different drugs administered in the treatment of malignant neoplasms or metastases and in antiresorptive therapies. Since 2010, denosumab, a monoclonal antibody whose
Sandra Bacián Martínez, Carlos Navarro Cuéllar, Carlos Navarro Vila, Edurne Palacios Weiss, Roser Pujol Romanyá, Álvaro del Amo Fernández de Velasco, Margarita Escrig de Teijeiro, José Luis del Castillo Pardo de Vera, Irene Rodríguez Pérez, Arturo Sánchez-Pérez, José J. Zamorano-León, Antonio López-Farré, María Isabel García-Hidalgo Alonso, Ignacio Navarro Cuéllar   +13 more
doaj   +1 more source

Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bisphosphonates [PDF]

, 2017
Osteonecrosis of the jaw (MRONJ) linked to bisphosphonate treatment has specific characteristics that render its therapeutic management challenging for clinicians.
Bermúdez Bejarano, Elena Beatriz, Castillo de Oyagüe, Raquel, Gutiérrez Corrales, Aida, Gutiérrez Pérez, José Luis, Romero Ruiz, Manuel María, Serrera Figallo, María Angeles, Torres Lagares, Daniel   +6 more
core   +1 more source